Imaging Acetadote Metabolism in Glioblastoma
Part of paid clinical trials in Dallas, Texas.
- Sponsor
- University of Texas Southwestern Medical Center
- Study ID
- NCT07387666
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Acetadote — DRUGAcetadote 150 mg/kg in 500 cc 5% dextrose IV over 1 hour
Study Details
This goal of this clinical trial is to evaluate how Acetadote affects metabolism in patients with glioblastoma. Drugs like Acetadote, which affect the level of damage in a cell (oxidative stress), may impact brain tumor metabolism and slow the growth of brain tumors. The investigators are evaluating how Acetadote affects glioblastoma metabolism by using MRI-based methods and by determining the changes in metabolism in brain tumor tissue resected from patients with a new diagnosis of glioblastoma.
Key Dates
- Start date
- Jun 18, 2026
- Status verified
- Jun 2026
- Primary completion
- Jul 1, 2027
- Completion
- Jul 1, 2028
Study Design
- Enrollment
- 10 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Acetadote 150 mg/kg IVAcetadote will be administered twice during this study: first before undergoing magnetic resonance spectroscopy (MRS) on Day 1 and second before undergoing surgical resection, which will take place between Days 2-21. Acetadote will be administered at a dose of 150 mg/kg IV over 60 minutes.
Primary Outcome Measure
To determine the effect of Acetadote on glioblastoma metabolism as measured by MRS. [ Time Frame: Day 1 and up to 21 days from Day 1 ]
Central Contacts
- Omar Raslan, MBBCH, MPH, CCRP214-648-7097
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | Omar Raslan, MBBCH, MPH, CCRP 214-648-7097 Evan Noch, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Dallas, TX
By condition
By specialty
By research site
Related Studies
- INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)PHASE2 · Recruiting · Patrick Wen, MD · Birmingham, Alabama
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBMPHASE1/PHASE2 · Recruiting · The Methodist Hospital Research Institute · Houston, Texas
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaPHASE2/PHASE3 · Recruiting · Global Coalition for Adaptive Research · Birmingham, Alabama